Skip to main content

Table 1 Antibiotic resistance pattern of Enterococcus faecalis isolates, no. (%)

From: Phenotypic and genotypic characterization of glycopeptide, aminoglycoside and macrolide resistance among clinical isolates of Enterococcus faecalis: a multicenter based study

Antimicrobial agent

No. (%) of vancomycin-resistant isolates

(N = 53) (%)

No. (%) of vancomycin-susceptible isolates

(N = 179) (%)

Total no. (%) of isolates

(N = 232) (%)

S

I

R

S

I

R

S

I

R

Teicoplanin

2 (3.8)

0 (0)

51 (96.2)

174 (97.2)

5 (2.8)

0 (0)

176 (75.8)

5 (2.2)

51 (22.0)

Ampicillin

22 (41.5)

31 (58.5)

146 (81.5)

33 (18.5)

168 (72.4)

64 (27.6)

Tetracycline

5 (9.5)

0 (0)

48 (90.5)

10 (5.5)

0 (0)

169 (94.5)

15 (6.5)

0 (0)

217 (93.5)

Ciprofloxacin

1 (1.8)

2 (3.8)

50 (94.4)

9 (5.0)

35 (19.5)

135 (75.5)

10 (4.0)

37 (16.0)

185 (80.0)

Erythromycin

0 (0)

0 (0)

53 (100)

5 (2.7)

25 (14.0)

149 (83.3)

5 (2.3)

25 (10.7)

202 (87.0)

Nitrofurantoin

43 (81.2)

0 (0)

10 (18.8)

155 (86.5)

0 (0)

24 (13.5)

198 (85.3)

0 (0)

34 (14.7)

Rifampin

16 (30.2)

13 (24.5)

24 (45.3)

69 (38.5)

39 (21.8)

71 (39.7)

85 (36.6)

52 (22.4)

95 (41.0)

Gentamicin

10 (18.9)

0 (0)

43 (81.1)

102 (57.0)

0 (0)

77 (43.0)

110 (47.5)

0 (0)

122 (52.5)

Linezolid

53 (100)

0 (0)

0 (0)

179 (100)

0 (0)

0 (0)

232 (100)

0 (0)

0 (0)

Fosfomycin

53 (100)

0 (0)

0 (0)

179 (100)

0 (0)

0 (0)

232 (100)

0 (0)

0 (0)